The Evidence for Stenting in Femoropopliteal Occlusive Disease

References

• Rogers J. H., Laird J. R. Overview of New Technologies for Lower Extremity Revascularization. Circulation, 2007, 116: 2072–2085.
   Google Scholar
• Norgren L., Hiatt W. R., Dormandy J. A., Nehler M. R., Harris K. A., Fowkes F. G., on behalf of the TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg, 2007, 45 (Suppl 1): S5- S67.
   Google Scholar
• Johnston K. W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology, 1992, 183: 767–71.
   Google Scholar
• Minar E., Pokrajac B., Maca T. et al. Endovascular brachythera-py for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation, 2000, 102: 2694–9.
   Google Scholar
• Capek P., McLean G. K., Berkowitz H. D. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation, 1991, 83: i70–80.
   Google Scholar
• Cejna M., Thurnher S. A., Illiasch H. et al. PTA vs Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomised study. J Vasc Interven Radiol, 2001, 12: 23–31.
   Google Scholar
• Vroegineweij D., Vos L. D., Tielbeek A. V., Buth J., vd Bosch H. C. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol, 1997, 20: 420–5.
   Google Scholar
• Grimm J., Muller-Hulsbeck S., Jahnke T., Hilbert C., Brossmann J., Heller M. Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Intervent Radiol, 2001, 12: 935–42.
   Google Scholar
• Zdanowski Z., Albrechtsson U., Lundin A. et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions ? A randomized controlled study. Int Angiol, 1999, 18: 251–5.
   Google Scholar
• Becquemin J. P., Favre J. P., Marzelle J., Nemoz C., Corsin C., Leizorovicz A. Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomised study. J Vasc Surg, 2003, 37: 487–94.
   Google Scholar
• Dormandy J. A., Rutherford B. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic InterSociety Consensus (TASC). J Vasc Surg, 2000, 31: S1–S296.
   Google Scholar
• Muradin G. S., Bosch J. L., Stijnen T., Hunink M. G. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology, 2001, 221: 137–45.
   Google Scholar
• Mwipatayi B. P., Hockings A., Hofmann M., Garbowski M., Sieunarine K. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis. J Vasc Surg, 2008, 47: 461–9.
   Google Scholar
• Duda S. H., Bosiers M., Lammer J. et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther, 2006, 13: 701–710.
   Google Scholar
• Sabeti S., Schillinger M., Amighi J. et al. Patency of nitinol vs. Wallstents in the superficial femoral artery - a propensity score adjusted analysis. Radiology, 2004, 232: 516–21.
   Google Scholar
• Schillinger M., Sabeti S., Loewe C. et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006, 354: 1879–88.
   Google Scholar
• Schillinger M., Sabeti S., Dick P. et al. Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting. Circulation, 2007, 115: 2745–49.
   Google Scholar
• Krankenberg H., Schlüter M., Steinkamp H. J. et al. Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length. The Femoral Artery Stenting Trial (FAST). Circulation, 2007, 116: 285–92.
   Google Scholar
• Duda S. H., Pusich B., Richter G. et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-months results. Circulation, 2002, 106: 1505–9.
   Google Scholar
• Scheinert D., Scheinert S., Sax J. et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol, 2005, 45: 312–5.
   Google Scholar
• Scheinert D. Oral presentation at LINC 2008, Leipzig.
   Google Scholar
• Kedora J., Hohmann S., Garrett W., Munschaur C., Theune B., Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg, 2007, 45: 10–16.
   Google Scholar
• Adam D. J., Beard J. D., Cleveland T. et al. Bypass surgery versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet, 2005, 366: 1925–34.
   Google Scholar
• Schillinger M., Mlekusch W., Haumer M. et al. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther, 2003, 10: 288–297.
   Google Scholar